Expert Rev Mol Diagn. 2010;10(1):49-64. With the ultimate goal of enabling personalized medicine for PC, massive efforts have been undertaken to identify new and better diagnostic, prognostic and ...
SOX2 is a member of SOX (SRY-related high mobility group box) family of transcription factors. We found that SOX2 was expressed in murine prostates during budding morphogenesis and in neuroendocrine ...
The core foundation of precision medicine, and in turn, precision oncology, is a personalized approach to treatment that focuses on targeting specific molecular features that impact how cancer cells ...
Prostate cancer is the second leading cause of cancer death in men. 1 Although the most recent data suggest that the incidence of death from this disease is on the decline owing to the advent of the ...
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Veracyte, Inc. (Nasdaq: VCYT), a leading cancer diagnostics company, today announced that its market-leading Decipher Prostate Genomic Classifier is the ...
Allogeneic Vaccination With a B7.1 HLA-A Gene-Modified Adenocarcinoma Cell Line in Patients With Advanced Non–Small-Cell Lung Cancer The incidence of prostate cancer is frequent, occurring in almost ...
A genetic variant implicated in several cancers by genome-wide association studies (GWAS) has been found to drive increased expression of a known oncogene in the prostate. The study, published July ...
Tumor Necrosis Factor-α–Induced Protein 3 As a Putative Regulator of Nuclear Factor-κB–Mediated Resistance to O6-Alkylating Agents in Human Glioblastomas EZH2 is a member of the polycomb group of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback